Salicylate intoxication

Journal of Intensive Care Medicine

Volumn 12, Issue 2, 1997, Pages 66-78

  Yip, Luke ^b   Jastremski, Michael S ^b   Dart, Richard C ^a  

^a ROCKY MOUNTAIN POISON AND DRUG CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG; SALICYLIC ACID;

ACID BASE BALANCE; CLINICAL FEATURE; DRUG ABSORPTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG OVERDOSE; ELECTROLYTE BALANCE; EXTRACORPOREAL CIRCULATION; FLUID BALANCE; HEMODIALYSIS; HYPOKALEMIA; INTENSIVE CARE; INTOXICATION; KETOACIDOSIS; LONG TERM CARE; METABOLIC ACIDOSIS; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; REVIEW; STOMACH LAVAGE;

EID: 0030898283     PISSN: 08850666     EISSN: None     Source Type: Journal    
DOI: 10.1177/088506669701200202     Document Type: Review

References (140)

1. Raschke R, Arnold-Capell PA, Richeson R, et al. Refractory hypoglycemia secondary to topical salicylate intoxication. Arch Intern Med 1991;151:591-593
2. Pec J, Strmenova M, Palencarova E, et al. Salicylate intoxication after use of topical salicylic acid ointment by a patient with psoriasis. Cutis 1992;50:307-309
3. Smith PK, Gleason HL, Stoll CG, et al. Studies on the pharmacology of salicylates. J Pharmacol Exp Ther 1946; 87:237-255
4. Morgan AG, Polak A. The excretion of salicylate in salicylate poisoning. Clin Sci 1971;41:475-484
5. Prescott LF, Balali-Mood M, Critchley JAJH, et al. Diuresis or urinary alkalinisation for salicylate poisoning? Br Med J 1982;285:1383-1386
6. Smith MJH, Irving KD. The effect of salicylate on the passage of a barium meal in the rat. Br J Radiol 1955;28:39-41
7. Smith MJH. The metabolic basis of the major symptoms in acute salicylate intoxication. Clin Toxicol 1968;1:387-407
8. Tenny SM, Miller RM. The respiratory and circulatory actions of salicylate. Am J Med 1955;19:498-508
9. Cameron IR, Semple SJG. The central respiratory stimulant action of salicylates. Clin Sci 1968;35:391-401
10. Silva PRM, Fonseca-Costa A, Zin WA, et al. Respiratory and acid-base parameters during salicylic intoxication in dogs. Braz J Med Biol Res 1986;19:279-286
11. Brody TM. Action of sodium salicylate and related compounds on tissue metabolism in vitro. J Pharmacol Exp Ther 1956;117:39-51
12. 14C from labelled pyruvate into the soluble intermediates of isolated rat tissues. Biochem J 1961;79:271-275
13. Yoshida T, Metcoff J, Kaiser E. A metabolic lesion in salicylate intoxication. Am J Dis Child 1961;102:511-514
14. Kaplan EH, Kennedy J, Davis J, Effects of salicylate and other benzoates on oxidative enzymes of the tricarboxylic acid cycle in rat tissue homogenates. Arch Biochem 1954;51:47-61
15. Bryant C, Smith MJH, Mines WJW. Effects of salicylate and gamma resorcylate on the metabolism of radioactive succinate and fumarate by rat-liver mitochondria and on dehydrogenase enzymes. Biochem J 1963;86:391-396
16. Schwartz R, Landy G. Organic acid excretion in salicylate intoxication. J Pediatr 1965;66:658-666
17. Hill JB. Experimental salicylate poisoning: observations on the effects of altering blood pH on tissue and plasma salicylate concentrations. Pediatrics 1971;47:658-665
18. Hill JB, Salicylate intoxication. N Engl J Med 1973; 288:1110-1113
19. Goldberg MA, Barlow CF, Roth LJ. The effects of carbon dioxide on the entry and accumulation of drugs in the central nervous system. J Pharmacol Exp Ther 1961; 131:308-318
20. Buchanan N, Rabinowitz L. Infantile salicylism - a reappraisal. J Pediatr 1974;84:391-395
21. Buchanan N, Kundig H, Eyberg B. Experimental salicylate intoxication in young baboons. J Pediatr 1975;86:225-232
22. Thurston JH, Pollock PG, Warren SK, et al. Reduced brain glucose with normal plasma glucose in salicylate poisoning. J Clin Invest 1970;49:2139-2145
23. Lutwak-Mann C. The effects of salicylate and cinchophen on enzymes and metabolic processes. Biochem J 1942;36:706-728
24. Hrnicek G, Skelton J, Miller WC. Pulmonary edema and salicylate intoxication. JAMA 1974;230:866-867
25. Heffner JE, Starkey T, Anthony P. Salicylate-induced non-cardiogenic pulmonary edema. West J Med 1979;130: 263-266
26. Heffner JE, Sahn SA. Salicylate-induced pulmonary edema, Ann Intern Med 1981;95:405-409
27. Hormaechea E, Carlson BW, Rogove H, et al. Hypovolemia, pulmonary edema and protein changes in severe salicylate poisoning. Am J Med 1979;66:1046-1050
28. Walters JS, Woodring JH, Stelling CB, et al. Salicylate-induced pulmonary edema. Radiology 1983;146:289-293
29. Fisher CJ, Albertson TE, Foulke GE. Salicylate-induced pulmonary edema: clinical characteristics in children. Am J Emerg Med 1985;3:33-37
30. Bowers RE, Brigham KL, Owen PJ. Salicylate pulmonary edema: the mechanism in sheep and review of the clinical literature. Am Rev Respir Dis 1977;115:261-268
31. Glauser FL, Egan P, Millen JE, et al. The effect of salicylate infusion on the alveolar epithelial membrane in the isolated perfused lung. Crit Care Med 1978;6:181-184
32. Clausen FW, Jager BV. The relation of the plasma salicylate level to the degree of hypoprothrombinemia. J Lab Clin Med 1946;31:428-436
33. Mongan E, Kelly P, Nies K, et al. Tinnitus as an indication of therapeutic serum salicylate levels. JAMA 1973;226;142-145
34. Myers EN, Bernstein JM, Fostiropolous G. Salicylate ototoxicity a clinical study. N Engl J Med 1965;11:587-590
35. Crichton JU, Elliott GB. Salicylate - a dangerous drug in infancy and childhood. Can Med Assoc J 1960;83: 1144-1147
36. Gaudreault P, Temple AR, Lovejoy FH. The relative severity of acute versus chronic salicylate poisoning in children: a clinical comparison. Pediatrics 1982;70:566-569
37. Winters RW, White JS, Hughes MC, et al. Disturbances of acid-base equilibrium in salicylate intoxication. Pediatrics 1959;23:260-285
38. Done AK. Treatment of salicylate poisoning: review of personal and published experiences. Clin Toxicol 1968;1: 451-467
39. Snodgrass W. Salicylate toxicity following therapeutic doses in young children. Clin Toxicol 1981;18:247-259
40. Temple AR, Acute and chronic effects of aspirin toxicity and their treatment. Arch Intern Med 1981;141:364-368
41. Dove DJ, Jones T. Delayed coma associated with salicylate intoxication. J Pediatr 1982;100:493-496
42. Curry SC. Salicylates. In: Tintinalli JE, Krome RL, Ruiz E, eds. Emergency medicine: a comprehensive study guide, ed 3. New York: McGraw-Hill International, 1992:589-593
43. Done AK. Aspirin overdosage: incidence, diagnosis, and management, Pediatrics 1978;62(suppl):890-897
44. Segar WE, Holliday MA. Physiologic abnormalities of salicylate intoxication. N Engl J Med 1958;259:1191-1198
45. Anderson RJ, Potts DE, Gabow PA, et al. Unrecognized adult salicylate intoxication, Ann Intern Med 1976;85: 745-748
46. Proudfoot AT. Toxicity of salicylates. Am J Med 1983;75(suppl)14:99-103
47. Proudfoot AT, Brown SS. Acidaemia and salicylate poisoning in adults. Br Med J 1969;2:547-550
48. Gabow PA, Anderson RJ, Potts DE, et al. Acid-base disturbances in the salicylate-intoxicated adult. Arch Intern Med 1978;138:1481-1484
49. Chapman BJ, Proudfoot AT, Adult salicylate poisoning: deaths and outcome in patients with high plasma salicylate concentrations. Q J Med 1989;2:699-707
50. Greer HD III, Ward HP, Corbin KB. Chronic salicylate intoxication in adults. JAMA 1965;193:555-558
51. Paul BN. Salicylate poisoning n the elderly: diagnostic pitfalls. J Am Geriatr Soc 1972;20:387-390
52. Anderson RJ. Asterixis as a manifestation of salicylate toxicity. Ann Intern Med 1981;95:188-189
53. Steele TE, Morton WA. Salicylate-induced delirium, Psychosomatics 1986;27;455-456
54. Pei YPC, Thompson DA. Sever salicylate intoxication mimicking septic shock. Am J Med 1987;82:381-382
55. Leatherman JW, Schmitz PG. Fever, hyperdynamic shock, and multiple-system organ failure: a pseudo-sepsis syndrome associated with chronic salicylate intoxication. Chest 1991;100:1391-1396
56. Bailey RB, Jones SR. Chronic salicylate intoxication a common cause of morbidity in the elderly. J Am Geriatr Soc 1989;37:556-561
57. Anderson CJ, Kaufman PL, Sturm RJ. Toxicity of combined therapy with carbonic anhydrase inhibitors and aspirin. Am J Ophthalmol 1978;86:516-519
58. Hurwitz GA, Wingfield W, Cowart TD, et al. Toxic interaction between salicylates and a carbonic anhydrase inhibitor: the role of cerebral edema. Vet Hum Toxicol 1980;22(suppl 2);42-44
59. Cowan RA, Hartnell GG, Lowdell CP, et al. Metabolic acidosis induced by carbonic anhydrase inhibitors and salicylates in patients with normal renal function. Br Med J 1984;289:347-348
60. Heller I, Halevy J, Cohen S, et al. Significant metabolic acidosis induced by acetazolamide: not a rare complication. Arch Intern Med 1985;145:1815-1817
61. Done AK. Significance of measurements of salicylate in blood in cases of acute ingestion. Pediatrics 1960;26: 800-807
62. Kwong TC, Laczin J, Baum J. Self-poisoning with entericcoated aspirin. Am J Clin Pathol 1983;80:888-890
63. Henry AF, Overdose of enterophen. Can Med Assoc J 1983;128:1142
64. Leonards JR, Levy G. Absorption and metabolism of aspirin administered in enteric-coated tablets. JAMA 1965;193: 93-98
65. Todd PJ, Sills JA, Harris F. Problems with overdoses of sustained-release aspirin. Lancet 1981;1:777
66. Wortzman DJ, Grunfeld A. Delayed absorption following enteric-coated aspirin overdose. Ann Emerg Med 1987;16:434-436
67. Handy CA. Radiopacity of oral nonliquid medications. Radiology 1971;98:525-533
68. O'Brien RP, McGeehan PA, Helmeczi AW, et al. Detectability of drug tablets and capsules by plain radiograph. Am J Emerg Med 1986;4:302-312
69. Savitt DL, Hawkins HH, Roberts JR. The radiopacity of ingested medications. Ann Emerg Med 1987;16:331-339
70. Poisoning with enteric-coated aspirin (editorial). Lancet 1981;2:130
71. Baum J. Enteric-coated aspirin and the problem of gastric retention. J Rheumatol 1984;11:250-251
72. Bogacz K, Caldron P. Enteric-coated aspirin bezoar: elevation of serum salicylate level by barium study. Am J Med 1987;83:783-786
73. Springer DJ, Groll A. Poisoning with enteric-coated acetylsalicylic acid complicating gastric outlet obstruction. Can Med Assoc J 1980;122:1032-1034
74. Sogge MR. Lavage to remove enteric-coated aspirin and gastric outlet obstruction. Ann Intern Med 1977;87:721-722
75. Harris FC. Pyloric stenosis: hold up of enteric coated aspirin tablets. Br J Med 1973;60:979-981
76. Kirshenbaum LA, Mathews SC, Sitar DS, et al. Whole-bowel irrigation versus activated charcoal in sorbitol for the ingestion of modified-release pharmaceuticals. Clin Pharmacol Ther 1989;46:264-271
77. Levy G, Tsuchiya T. Effect of activated charcoal on aspirin absorption in man. Clin Pharmacol Ther 1972;13:317-322
78. Filippone GA, Fish SS, Lacouture PG, et al. Reversible adsorption (desorption) of aspirin from activated charcoal. Arch Intern Med 1987;147:1390-1392
79. Barone JA, Raia JJ, Huang YC. Evaluation of the effects of multiple-dose activated charcoal on the absorption of orally administered salicylate in a simulated toxic ingestion model. Ann Emerg Med 1988;17:34-37
80. Mayersohn M, Perrier D, Picchioni AL. Evaluation of a charcoal-sorbitol mixture as antidote for oral aspirin overdose. Clin Toxicol 1977;11:561-567
81. Picchioni AL, Chin L, Gillespie T. Evaluation of activated charcoal-sorbitol suspension as an antidote. J Toxicol Clin Toxicol 1982;19:433-444
82. Easom JM, Caraccio TR, Lovejoy FH. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans. Clin Pharm 1982;1:154-156
83. Keller RE, Schwab RA, Krenzelok EP. Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption. Ann Emerg Med 1990;19:654-656
84. Done AK. Salicylate poisoning. JAMA 1965;192:770-772
85. Done AK. Treatment of salicylate poisoning. Mod Treat 1967;4:648-670
86. Pierce AW. Salicylate poisoning, Pediatrics 1974;54:342-347
87. Ellenhorn MJ, Barceloux DH, Salicylates. Medical toxicology diagnosis and treatment of human poisoning. New York; Elsevier, 1988:561-572
88. Goldfrank LR, Bresnitz EA, Hartnett L, et al. Salicylates. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al eds. Goldfrank's toxicologic emergencies, ed 4. Norwalk, CT: Appleton and Lange, 1990:261-269
89. Riggs BS, Kulig K, Rumack BH. Current status of aspirin and acetaminophen intoxication. Pediatr Ann 1987;16:886-898
90. Levy G. Gastrointestinal clearance of drugs with activated charcoal (editorial). N Engl J Med 1982;307:676-678
91. Hillman RJ, Prescott LF. Treatment of salicylate poisoning with repeated oral charcoal. Br Med J 1985;291:1472
92. Yeakel D, Stemple C, Dougherty J. A prospective human crossover study on single versus multiple dose charcoal in salicylate ingestion. Ann Emerg Med 1988;17:439
93. Kirshenbaum LA, Mathews SC, Sitar DS, et al. Does multiple-dose charcoal therapy enhance salicylate excretion? Arch Intern Med 1990;150:1281-1283
94. Oliver TK, Dyer ME. The prompt treatment of salicylism with sodium bicarbonate. Am J Dis Child 1960;99:555-565
95. Whitten CF, Kesaree NM, Goodwin JF. Managing salicylate poisoning in children. Am J Dis Child 1961;101:178-194
96. Tschetter PN. Salicylism. Am J Dis Child 1963;106:134-146
97. Lawson AAH, Proudfoot AT, Brown SS, et al. Forced diuresis in the treatment of acute salicylate poisoning in adults. Q J Med 1969;38:31-48
98. Prescott LF. Clinical features and management of analgesic-poisoning. Human Toxicol 1984;3:75S-84S
99. Gabow PA. How to avoid overlooking salicylate intoxication. J Crit Illness 1986;1:77-85
100. Beveridge GW, Forshall W, Munro JF, et al. Acute salicylate poisoning in adults. Lancet 1987;1:1406-1409
101. Gumming G, Dukes DC, Widdowson G. Alkaline diuresis in treatment of aspirin poisoning. Br Med J 1964;2:1033-1036
102. Winchester JF, Gelfand MC, Knepshield JH, et al. Dialysis and hemoperfusion of poisons and drugs-update. Trans Am Soc Artif Intern Organs 1977;23:762-842
103. Schlesinger TG, Janz TG. The efficacy of continuous bicarbonate infusion in maintaining an alkaline pH. Ann Emerg Med 1989;18:916
104. Gordon IJ. Diuresis or urinary alkalinisation for salicylate poisoning? Br Med J 1983;286:147
105. Snodgrass WR. Salicylate toxicity. Pediatr Clin North Am 1986;33:381-391
106. Rumack BH. Salicylates. In: Behrman RE, Kliegman RM, Nelson WE, Vaughan VC III, eds. Nelson textbook of pediatrics, ed 14. Philadelphia: W.B. Saunders, 1992:1778-1779
107. Chan YL, Biagi B, Giebish G. Control mechanism for bicarbonate transport across the rat proximal convoluted tubule. Am J Physiol 1982;242:532-543
108. Crump CH, Murdaugh HV Jr. Studies of salicylate intoxication in dogs. Clin Res 1959;7:298
109. Prescott LF, Critchley JAJH, Proudfoot AT. Diuresis or urinary alkalinisation for salicylate poisoning? Br Med J 1983;286:147
110. Sørensen SC, Adult respiratory-distress syndrome in salicylate intoxication. Lancet 1979;1:1025
111. Berk WA, Andersen JC. Salicylate-associated asystole: report of two cases. Am J Med 1989;86:505-506
112. Yip L, Dart RC, Gabow PA, Concepts and controversies in salicylate toxicity. Emerg Med Clin North Am 1994;12; 351-364
113. Kaplan SA, del Carmen FT. Experimental salicylate poisoning: observations on the effects of carbonic anhydrase inhibitor and bicarbonate, Pediatrics 1958;21:762-769
114. Reed JR, Palmisano PA. Central nervous system salicylate, Clin Toxicol 1975;8:623-631
115. Schwanz R, Fellers FX, Knapp J, et al. The renal response to administration of acetazolamide (Diamox®) during salicylate intoxication. Pediatrics 1959;23:1103-1114
116. Feuerstein RC, Finberg L, Fleishman E. The use of acetazoleamide in the therapy of salicylate poisoning. Pediatrics 1960;25:215-227
117. Reimold EW, Worthen HG, Reilly TP Jr. Salicylate poisoning: comparison of acetazolamide administration and alkaline diuresis in the treatment of experimental salicylate intoxication in puppies. Am J Dis Child 1973;125:668-674
118. Samiy AH, Oken DE, Rees SB, et al. Effect of 2-amino-2-hydroxymethyl-1, 3-propanediol on electrolyte excretion. Ann NY Acad Sci 1961;92:570-578
119. Strauss J, Nahas GG. Use of amine buffer (THAM) in treatment of acute salicylate intoxication. Proc Soc Biol Med 1960;105:348-351
120. Strauss J, Nahas GG, James S, et al. Effects of 2-amino-2-hydroxymethyl-1,3-propanediol on renal function in reference to salicylate and glucose. Ann NY Acad Sci 1961;92:579-593
121. Israels S, Davies H. The effects of tris-hydroxymethyl aminomethane (THAM) on renal excretion of salicylate. Am J Dis Child 1961;102:118-120
122. Gemmill WD, Sechrist GL, Oliver TK Jr, et al. The use of Tris buffer to alkalinize the urine of young children with severe salicylism. J Pediatr 1963;63:732
123. Kaplan SA. Tris (hydroxymethyl) aminomethan (THAM) - a new buffer for therapeutic use. Am J Dis Child 1962;103:33-34
124. Nahas GG. The clinical pharmacology of THAM [tris(hydroxymethyl)aminomethanel. Clin Pharmacol Ther 1963;4:784-803
125. Strauss J. Tris (hydroxymethyl) amino-methane (THAM): a pediatric evaluation. Pediatrics 1968;41:667-689
126. Waddell WJ, Bates RG. Intracellular pH. Physiol Rev 1969;49:285-326
127. James JA, Kimbell L, Read WT. Comparison of exchange transfusion, intermittent peritoneal lavage, and hemodialysis as means for removing salicylate. Pediatrics 1962;29; 442-447
128. Jacobsen D, Wiik-Larsen E, Bredesen JE. Haemodialysis or haemoperfusion in severe salicylate poisoning? Human Toxicol 1988;7:161-163
129. Done AK, Otterness LJ. Exchange transfusion in the treatment of oil of wintergreen (methyl salicylate) poisoning. Pediatrics 1956;18:80-85
130. Rentsch JB, Bradley A, Marsh SB. Two cases of salicylate intoxication successfully treated by exchange transfusion. Am J Dis Child 1959;98:778-784
131. Elliott GB, Crichton JU. Peritoneal dialysis in salicylate intoxication. Lancet 1960;2:840-842
132. Leikin SL, Emmanouilides GC. The use of exchange transfusion in salicylate intoxication. J Pediatr 1960;57:715-720
133. Etteldorf JN, Dobbins WT, Summitt RL, et al. Intermittent peritoneal dialysis using 5 per cent albumin in the treatment of salicylate intoxication in children. J Pediatr 1961; 58:226-236
134. Schlegel RJ, Altstatt LB, Canales L, et al. Peritoneal dialysis for severe salicylism: an evaluation of indications and results. J Pediatr 1966;69:553-562
135. Klein-Schwartz, Oderda GM. Poisoning in the elderly epidemiological, clinical and management considerations. Drugs Aging 1991;1:67-89
136. Locket S. Hemodialysis in the treatment of acute poisoning. Proc R Soc Med 1970;63:427-430
137. McGuigan MA, A two-year review of salicylate deaths in Ontario. Arch Intern Med 1987;147:510-512
138. Proudfoot AT. Salicylates and salicyamide. In: Haddad LM, Winchester JF, eds. Clinical management of poisoning and drug overdose, ed 2. Philadelphia: W.B. Saunders, 1990: 909-920
139. Schreiner GE, Teehan BP. Dialysis of poisons and drugs-annual review, Trans Am Soc Artif Intern Organs 1972; 18:563-599
140. Vale A, Meredith T, Buckley B. Eliminating poisons. Br Med J 1984;289:366-369